
LY-3000328
CAS No. 1373215-15-6
LY-3000328 ( LY3000328 )
产品货号. M11538 CAS No. 1373215-15-6
LY-3000328 是一种有效的、高选择性的组织蛋白酶 S 抑制剂,IC50 为 7.7 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1126 | 有现货 |
![]() ![]() |
5MG | ¥1790 | 有现货 |
![]() ![]() |
10MG | ¥2365 | 有现货 |
![]() ![]() |
25MG | ¥4155 | 有现货 |
![]() ![]() |
50MG | ¥6043 | 有现货 |
![]() ![]() |
100MG | ¥8505 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称LY-3000328
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述LY-3000328 是一种有效的、高选择性的组织蛋白酶 S 抑制剂,IC50 为 7.7 nM。
-
产品描述LY-3000328 is a potent, highly selective cathepsin S inhibitor with IC50 of 7.7 nM; dispalys >500-fold selectivity over cathepsin L, cathepsint K, cathepsin B, and cathepsin V; shows efficacy in a CaCl2-induced AAA (Abdominal Aortic Aneurysm) in vivo model.Other Indication Phase 1 Clinical.
-
体外实验LY 3000328 maintains excellent in vitro potency and selectivity. LY 3000328 shows low in vitro CYP450 inhibition (<15% at 10 μM for CYP3A4, CYP2D6, and CYP2C9); low in vitro metabolism in mouse, rat, dog, and human liver microsomes (<20% after 30 min incubation at 4 μM); and good permeability (MDCK A-B>4%). At a 100 μM concentration of LY 3000328 there is only 6% displacement of [3H]-astemizole in an assay with HEK293 membrane preparation, indicating low potential of hERG blockade. LY 3000328 is a potent and specific inhibitor of cathepsin S (CatS). Inhibition of CatS activity in plasma would be 50% of maximal when LY 3000328 plasma concentration is approximately 60 ng/mL.
-
体内实验The efficacies of LY 3000328 is studied in a mouse model of abdominal aortic aneurysm (AAA). In this model, inflammation is induced using CaCl2 applied to the ablumenal surface. It is shown that features of the disease state in this model resemble those of human AAA. LY 3000328 exhibits a dose-responsive aortic diameter reduction at 1, 3, 10, and 30 mg/kg. At the lowest dose of 1 mg/kg of LY 3000328, the aortic diameter is reduced by 58%, then 83% at 3 mg/kg, and 87% at 10 mg/kg. The exposure (AUC) for both compounds increased in a dose-dependent manner, suggesting that the drug disposition properties of LY 3000328 are favorable.
-
同义词LY3000328
-
通路Metabolic Enzyme/Protease
-
靶点Cathepsin
-
受体Cathepsin
-
研究领域Other Indications
-
适应症Other Disease
化学信息
-
CAS Number1373215-15-6
-
分子量484.528
-
分子式C25H29FN4O5
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 50 mg/mL 103.19 mM
-
SMILESO=C(O[C@H]1COC2=C(C=C(N3CCN(C4COC4)CC3)C=C2)[C@@H]1NC(C5=CC=C(F)C=C5)=O)NC
-
化学全称(3R,4S)-4-(4-fluorobenzamido)-6-(4-(oxetan-3-yl)piperazin-1-yl)chroman-3-yl methylcarbamate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Jadhav PK, et al. ACS Med Chem Lett. 2014 Aug 27;5(10):1138-42.
2. Payne CD, et al. Br J Clin Pharmacol. 2014 Dec;78(6):1334-42.
3. Steimle A, et al. J Autoimmun. 2016 Dec;75:82-95.
产品手册




关联产品
-
L 873724
L 873724 是一种有效的选择性非碱性组织蛋白酶 K 抑制剂,IC50 为 0.2 nM。
-
MIV-247
MIV-247 (MIV247) 是一种有效的、选择性的、口服活性的组织蛋白酶 S 抑制剂,Ki 为 2.1 nM(人组织蛋白酶 S)。
-
N-CBZ-Phe-Arg-AMC
N-CBZ-Phe-Arg-AMC (Z-FR-AMC) is a substrate for serine proteases, including cathepsins, kallikrein and plasmin.Absorption/emission of substrate = 330/390 nm (weak fluorescence); absorption/emission of end product (AMC) = 342/441 nm (strong fluorescence).